Climate change is fueling a neurological health crisis, experts warn

Research explores the profound impact of climate change on neurological health, focusing on how rising temperatures, extreme weather, and air pollution exacerbate conditions like epilepsy, stroke, and sleep disorders, while calling for urgent research and mitigation strategies to address these vulnerabilities.

FDA OKs New Option for Rare Immune-Mediated Vasculitis

The FDA approved the asthma drug benralizumab (Fasenra) as a new therapy for adults with eosinophilic granulomatosis with polyangiitis (EGPA), drugmaker AstraZeneca announced on Wednesday.

September 19, 2024

Aurinia appoints founder to board in handshake with MKT Capital

As Aurinia Pharmaceuticals explores a potential sale and refreshes its board following pushback from MKT Capital and another investor group, the drugmaker has agreed to

September 22, 2023

Repeat PlGF testing for pre-eclampsia not beneficial, research finds

A single test to speed up diagnosis of a serious disease in pregnant women does not need to be repeated, new research has found.

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.